tiprankstipranks
Eledon Pharmaceuticals (DE:2TK)
FRANKFURT:2TK
Germany Market
2TK
Eledon Pharmaceuticals
RESEARCH TOOLSreports

Eledon Pharmaceuticals (2TK) Stock News & Sentiment

1 Followers
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
Premium
Ratings
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
28d ago
ELDN
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
Premium
Company Announcements
Eledon’s BESTOW Trial Completion: What Tegoprubart Could Mean for Transplant Investing
2M ago
ELDN
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
Premium
Company Announcements
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
3M ago
8K
ELDN
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
Premium
Ratings
Analyst Reiterates Buy on Eledon as Tegoprubart Data Impresses; Price Target Maintained at $6
3M ago
ELDN
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Eledon Pharmaceuticals, Inc. (ELDN) Q4 Earnings Cheat Sheet
6M ago
ELDN
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
Premium
Ratings
Compelling Tegoprubart Data in Type 1 Diabetes Transplantation Support Buy Rating on Eledon
6M ago
ELDN
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
Premium
Ratings
Eledon Pharmaceuticals: Sustained Tegoprubart Efficacy, Differentiated Safety, and Upcoming Transplant Catalysts Support Buy Rating
8M ago
ELDN
More DE:2TK News >

2TK News on the Web

Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Eledon Therapeutics: Buy Rating Reaffirmed on Strong Cash Runway and Tegoprubart Data; Price Target Unchanged at $8
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Natera, Eledon Partner On Kidney Transplant Monitoring Test For Phase 3 Trial; Stock Up
rttnews
Bullish
Analysts’ Top Healthcare Picks: Diamedica Therapeutics (DMAC), Guardian Pharmacy Services, Inc. Class A (GRDN)
TipRanks News
Bullish
Guggenheim Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)
TipRanks News
Bullish
Eledon Pharmaceuticals Expands Authorized Shares After Stockholder Vote
TipRanks News
Neutral
Noble Financial Sticks to Its Buy Rating for Eledon Pharmaceuticals (ELDN)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2TK’s Media Buzz Sentiment?
Currently, no data Available
What is DE:2TK’s weekly average amount of articles?
In an average week, 1.75 articles about DE:2TK are published.
    What is DE:2TK’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    NTLAIntellia Therapeutics
    BAYRYBayer
    GHGuardant Health
    ROIVRoivant Sciences
    CMPSCOMPASS Pathways
    Showing the stocks with the most bullish news sentiment over the past week